Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Library Archives
Volume 23, 2019 Archive

Six issues from 2019 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2019
Vol. 23 No. 1
Volume 23, Number 1
March/April 2019
Vol. 23 No. 2
Volume 23, Number 2
May/June 2019
Vol. 23 No. 3
Volume 23, Number 3
July/August 2019
Vol. 23 No. 4
Volume 23, Number 4
September/October 2019
Vol. 23 No. 5
Volume 23, Number 5
November/December 2019
Vol. 23 No. 6
Volume 23, Number 6

Volume 23, 2019 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: The Cost of Information
Allen Loyd V Jr
Jan/Feb 2019
Pg. 4

An Outlook on the European and Italian Rules to Guarantee Magistral Formulas
Selmin Francesca
, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
Jan/Feb 2019
Pg. 6-12

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
Jan/Feb 2019
Pg. 14-21

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T
, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019
Pg. 32-33

Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
Jan/Feb 2019
Pg. 35-44

Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
Jan/Feb 2019
Pg. 47-49

Calculations
Stockton Shelly J
Jan/Feb 2019
Pg. 50

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 54

Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 55

Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
Jan/Feb 2019
Pg. 56

Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 57

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Orodispersible Film
Allen Loyd V Jr
Jan/Feb 2019
Pg. 59

Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Allen Loyd V Jr
Jan/Feb 2019
Pg. 60

Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 61

Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L
, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
Jan/Feb 2019
Pg. 62-64

Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson
, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019
Pg. 65-69

Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
Jan/Feb 2019
Pg. 70-76

Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C
, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2019
Pg. 77-81

Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah
, Agu Remigius U
Jan/Feb 2019
Pg. 82-87

PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
Mar/Apr 2019
Pg. 92

Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
Mar/Apr 2019
Pg. 94-104

Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
Mar/Apr 2019
Pg. 106-111

Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
Mar/Apr 2019
Pg. 113-119

Patient Access Is a Patient Safety Issue
Pore David
Mar/Apr 2019
Pg. 120-121

Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130

Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations
Allen Loyd V Jr
Mar/Apr 2019
Pg. 135-143

Calculations
Stockton Shelly J
, Drinnon Stephen D
Mar/Apr 2019
Pg. 144

Acetaminophen 50% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 146

Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 147

Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 148

Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
Mar/Apr 2019
Pg. 149

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 150

Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2019
Pg. 151

Rosuvastatin 20-mg/5-mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 152

Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 153

Towards the Importance of a Roller Mill in Compounding Practice: An Experimental Approach
Polonini Hudson
, Loures da Silva Sharlene, Batista Patrício Fernando, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Mar/Apr 2019
Pg. 154-156

Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Mar/Apr 2019
Pg. 157-162

Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit
Lardinois Benjamin
, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M
Mar/Apr 2019
Pg. 163-166

Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure
Ip Kendice
, Banov Daniel, Bassani Gus, Morgan Latisha
Mar/Apr 2019
Pg. 167-175

PreScription: Honesty/Ethics in Professions: The Gallup Polls
Allen Loyd V Jr
May/Jun 2019
Pg. 180

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

Summary of Educational Offerings Provided by Compounding Support Companies in 2019
Stevens J Tyler
May/Jun 2019
Pg. 188-191

Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
May/Jun 2019
Pg. 192-199

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
May/Jun 2019
Pg. 200-207

Can We Fix It?
Brunner Scott
May/Jun 2019
Pg. 208-209

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
May/Jun 2019
Pg. 211-216

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Calculations
Stockton Shelly J
May/Jun 2019
Pg. 229

Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 230

Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 231

Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Allen Loyd V Jr
May/Jun 2019
Pg. 232

Flunisolide Nasal Spray
Allen Loyd V Jr
May/Jun 2019
Pg. 233

Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 234

Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2019
Pg. 235

Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
May/Jun 2019
Pg. 236

Valsartan 16-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 237

Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K
, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
May/Jun 2019
Pg. 238-244

Trends of Extemporaneous Drug Prescription in Latvia in 2017
Kiselova Olga
, Maurina Baiba, Sidlovska Venta, Rogovska Irena
May/Jun 2019
Pg. 245-249

Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
Rashid Mamoon
, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
May/Jun 2019
Pg. 250-257

An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability
Reindel Kristin L
, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
May/Jun 2019
Pg. 258-263

PreScription: Temperatures by Degrees
Allen Loyd V Jr
Jul/Aug 2019
Pg. 268

Contamination Control in Compounding Areas
Mulder Kyle
, Gonzales Ben A
Jul/Aug 2019
Pg. 271-278

Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Newton David W
Jul/Aug 2019
Pg. 281-287

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future
Brunner Scott
Jul/Aug 2019
Pg. 294-296

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
Jul/Aug 2019
Pg. 299-303

Basics: Excipients Used in Nonsterile Compounding, Part 1
Allen Loyd V Jr
Jul/Aug 2019
Pg. 305-311

Calculations
Stockton Shelly J
, Drinnon Stephen D
Jul/Aug 2019
Pg. 312-313

Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Allen Loyd V Jr
Jul/Aug 2019
Pg. 314

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
Jul/Aug 2019
Pg. 315

Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2019
Pg. 316

Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
Jul/Aug 2019
Pg. 317

Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
Jul/Aug 2019
Pg. 318

Rifampin 25 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2019
Pg. 319

Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin
, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2019
Pg. 320-323

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina
, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jul/Aug 2019
Pg. 324-331

Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L
, York Anne E
Jul/Aug 2019
Pg. 325-339

Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches
Burrows Anna C
, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L
Jul/Aug 2019
Pg. 340-350

Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.
Jul/Aug 2019
Pg. 351

Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249.
Jul/Aug 2019
Pg. 351

PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc
Allen Loyd V Jr
Sep/Oct 2019
Pg. 356

Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George
, Daleo Charles, Batson SL
Sep/Oct 2019
Pg. 358-364

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
Sep/Oct 2019
Pg. 376-381

Threading the Needle
Brunner Scott
Sep/Oct 2019
Pg. 383-385

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019
Pg. 387-391

Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
Sep/Oct 2019
Pg. 393-396

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Calculations
Stockton Shelly J
Sep/Oct 2019
Pg. 404

Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 406

Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 407

Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 408

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 409

Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2019
Pg. 410

Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
Sep/Oct 2019
Pg. 411

Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
Sep/Oct 2019
Pg. 412

Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 413

Stability of Furosemide 5 mg/mL in Polypropylene Syringes
van der Schaar JAJ
, Grouls R, Franssen EJF, Crul M
Sep/Oct 2019
Pg. 414-417

Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Berisa Prado Silvia
, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Sep/Oct 2019
Pg. 418-421

The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E
, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Sep/Oct 2019
Pg. 422-427

The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E
, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019
Pg. 428-433

Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics
Lardinois Benjamin
, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Sep/Oct 2019
Pg. 434-437

Erratum: McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospice patient with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe : A case report. IJPC. 2012; 16(5): 364–368.
Sep/Oct 2019
Pg. 438

Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191.
Sep/Oct 2019
Pg. 438

PreScription: As Things Change….
Allen Loyd V Jr
Nov/Dec 2019
Pg. 444

Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
Nov/Dec 2019
Pg. 447-452

How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A
, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019
Pg. 454-461

Are You Part of the Solution or Part of the Problem?
Brunner Scott
Nov/Dec 2019
Pg. 462-464

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019
Pg. 467-471

Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
Nov/Dec 2019
Pg. 472-477

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Calculations
Stockton Shelly J
, Stover Emily M
Nov/Dec 2019
Pg. 484

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 486

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 489

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 491

Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Nov/Dec 2019
Pg. 492

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 493

Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
Nov/Dec 2019
Pg. 494

Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 495

Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah
, Agu Remigius U
Nov/Dec 2019
Pg. 496-503

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad
, Day A J
Nov/Dec 2019
Pg. 511-518

Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt
Graves Richard A
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
Nov/Dec 2019
Pg. 519-527

Return to Top